TRAF2 and B-cell non-Hodgkin lymphoma: These results suggest that TRAF2/3 deficiency per se does not cause B-cell malignancy frequently instead it permits B cells to survive better upon DNA damage to accumulate genetic alterations which may subsequently cause B-cell lymphomas.